103-111
Special Article
Fate of the abstracts presented at three Spanish clinical pharmacology congresses and reasons for unpublished research
E. Montané and X. Vidal
113-121
Clinical Trial
The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers
S. Efrati, M. Averbukh, V. Dishy, M. Faygenzo and L. Friedensohn, et al.
123-134
Clinical Trials
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
Angelo Tremblay, Jean-Philippe Chaput, Sonia Bérubé-Parent, Denis Prud’homme and Claude Leblanc, et al.
135-141
Pharmacodynamics
The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers
A. Van Hecken, M. Depré, I. De Lepeleire, C. Thach and M. Oeyen, et al.
143-149
Pharmacogenetics
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations
Tsukasa Uno, Takenori Niioka, Makoto Hayakari, Norio Yasui-Furukori and Kazunobu Sugawara, et al.
151-158
Pharmacokinetics and Disposition
Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist
Paul L. M. van Giersbergen and Jasper Dingemanse
159-163
Pharmacokinetics and Disposition
Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl
Robert Z. Harris, Margaret Salfi, Ed Posvar, David Hoelscher and Desmond Padhi
165-172
Pharmacokinetics and Disposition
Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases
Ying Hong, Peter J. Shaw, Bruce N. Tattam, Christa E. Nath and John W. Earl, et al.
173-179
Pharmacokinetics and Disposition
Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers
Annika Allqvist, Jun Miura, Leif Bertilsson and Rajaa A. Mirghani
181-187
Pharmacoepidemiology and Prescription
Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients
Maurits E. L. Arbouw, Kris L. L. Movig, Cees Neef, Henk-Jan Guchelaar and Toine C. G. Egberts
189-195
Pharmacoepidemiology and Prescription
Open AccessMedication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
J. Headley and K. Northstone
197-203
Pharmacoepidemiology and Prescription
Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994–2003
Paola Deambrosis, Cristina Saramin, Gianni Terrazzani, Luca Scaldaferri and Patrizia Debetto, et al.
205-209
Pharmacoepidemiology and Prescription
Incorrect use of orlistat and sibutramine in clinical practice
Anna Dahlin and Björn Beermann
211-216
Short Communication
Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes
Yuji Mano, Takashi Usui and Hidetaka Kamimura
217-218
Erratum
Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia
Kosuke Doki, Masato Homma, Keisuke Kuga, Kazutomi Kusano and Shigeyuki Watanabe, et al.
219
Announcement
CPT 2008, The IXth World Conference on Clinical Pharmacology and Therapeutics